FGF23 factories in iron deficiency and anemia of CKD

In this issue of Blood, Courbon et al 1 describe the effects of the phosphateregulating hormone fibroblast growth factor 23 (FGF23) on erythropoiesis in health, iron deficiency, and chronic kidney disease (CKD).

Authors

Institutions

Publication Details

Journal
Blood
Published
2026-08-27
DOI
https://doi.org/10.1182/blood.2026034346
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

FGF23 factories in iron deficiency and anemia of CKD

Myles Wolf
Blood
Parathyroid Disorders and Treatments
article

FGF23 factories in iron deficiency and anemia of CKD

Myles Wolf
article en

Abstract

In this issue of Blood, Courbon et al 1 describe the effects of the phosphateregulating hormone fibroblast growth factor 23 (FGF23) on erythropoiesis in health, iron deficiency, and chronic kidney disease (CKD).

BloodVol. 148(9)
Cornell University (US), Weill Cornell Medicine (US)
Zero hunger
Openalex Percentile: Top 11%
Parathyroid Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.